{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:44:21Z","timestamp":1793166261747,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P35219-B"],"award-info":[{"award-number":["P35219-B"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"ISCiii","doi-asserted-by":"crossref","award":["INVESTIGO 2022-C23.I01.P03.S0020-0000031"],"award-info":[{"award-number":["INVESTIGO 2022-C23.I01.P03.S0020-0000031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"ISCiii","doi-asserted-by":"crossref","award":["RICORS (RD24\/0007\/0031)"],"award-info":[{"award-number":["RICORS (RD24\/0007\/0031)"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"ISCiii","doi-asserted-by":"crossref","award":["PI21\/0147"],"award-info":[{"award-number":["PI21\/0147"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Giant cell arteritis (GCA) is a chronic granulomatous inflammatory disease involving large- and medium-sized arteries. The disease spectrum comprises cranial (C-GCA), extracranial (EC-GCA) and mixed phenotypes. Toll-like receptors (TLRs) in the affected arteries may play an important role in GCA pathogenesis. However, data on TLR and TLR-ligands expression pattern in GCA arteries are lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the expression of TLRs and putative ligands in temporal artery biopsies (TAB) from C-GCA, EC-GCA and isolated polymyalgia rheumatica (PMR) patients to establish a link between TLRs, antigen expression, and disease stage. To correlate the plasma levels of identified TLR-ligands with standard inflammatory markers (IL-6, CRP, ESR) in these patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Immunofluorescence staining of TLR2\/4\/7\/8, HMGB-1, SAA, fibrinogen, and p-glycoprotein was performed with TABs of six biopsy proven C-GCA, six EC-GCA, five PMR patients and seven age-matched controls. Association studies among plasma inflammatory markers were done with 139 PMR and 40 GCA patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The levels of TLR2\/4\/7\/8 and the alarmins HMGB-1, SAA, and fibrinogen were highly increased in C-GCA TABs in the sites of inflammation and less in EC-GCA TABs. P-glycoprotein was overexpressed in C-GCA TABs. Glucocorticoids or TAK1-inhibitor treatment decreased the fibrinogen- and SAA-mediated IL-6 production in control PBMCs. Plasma levels of SAA and fibrinogen associated strongly with CRP and ESR levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TLRs are overexpressed at the site of vascular inflammation in C-GCA and at a lower level in EC-GCA and PMR with negative TAB. Moreover, HMGB-1, SAA, and fibrinogen may serve as disease biomarkers of patients with C-GCA.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-025-01390-4","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T14:33:51Z","timestamp":1762958031000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Increased expression of Toll-like receptors and associated alarmins in temporal arteries of patients with giant cell arteritis"],"prefix":"10.1186","volume":"31","author":[{"given":"S.","family":"Seidlberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schirmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wietzorrek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Jim\u00e9nez-Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pardines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de las Fuentes Monreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Santos-Sierra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"5","key":"1390_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/MD.0000000000000033","volume":"93","author":"MA Alba","year":"2014","unstructured":"Alba MA, Garcia-Martinez A, Prieto-Gonzalez S, Tavera-Bahillo I, Corbera-Bellalta M, Planas-Rigol E, et al. Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patients. Medicine (Baltimore). 2014;93(5):194\u2013201.","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"1390_CR2","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1136\/ard.2010.140194","volume":"70","author":"L Alvarez Rodriguez","year":"2011","unstructured":"Alvarez Rodriguez L, Lopez-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marin MJ, et al. Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 2011;70(9):1677\u201383.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1390_CR3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.33411","volume":"64","author":"M Baldini","year":"2012","unstructured":"Baldini M, Maugeri N, Ramirez GA, Giacomassi C, Castiglioni A, Prieto-Gonzalez S, et al. Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia. Arthritis Rheum. 2012;64(3):854\u201365.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1390_CR4","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.3390\/jcm11061588","volume":"11","author":"S Castaneda","year":"2022","unstructured":"Castaneda S, Prieto-Pena D, Vicente-Rabaneda EF, Triguero-Martinez A, Roy-Vallejo E, Atienza-Mateo B, et al. Advances in the treatment of giant cell arteritis. J Clin Med. 2022;11(6):1588.","journal-title":"J Clin Med"},{"issue":"8","key":"1390_CR5","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/rheumatology\/key106","volume":"57","author":"F Ciccia","year":"2018","unstructured":"Ciccia F, Ferrante A, Guggino G, Cavazza A, Salvarani C, Rizzo A. CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis. Rheumatology (Oxford). 2018;57(8):1377\u201380.","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"1390_CR6","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1136\/ard.55.12.927","volume":"55","author":"MC Cid","year":"1996","unstructured":"Cid MC, Monteagudo J, Oristrell J, Vilaseca J, Pallares L, Cervera R, et al. Von Willebrand factor in the outcome of temporal arteritis. Ann Rheum Dis. 1996;55(12):927\u201330.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1390_CR7","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1136\/annrheumdis-2015-207655","volume":"75","author":"M Connolly","year":"2016","unstructured":"Connolly M, Rooney PR, McGarry T, Maratha AX, McCormick J, Miggin SM, et al. Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms. Ann Rheum Dis. 2016;75(7):1392\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1390_CR8","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/art.34356","volume":"64","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Kremers HM, Schmidt WA, Schirmer M, Salvarani C, et al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism\/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64(4):943\u201354.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1390_CR9","first-page":"506","volume":"56","author":"C Dejaco","year":"2017","unstructured":"Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56(4):506\u201315.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"1390_CR10","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.109.872903","volume":"121","author":"J Deng","year":"2010","unstructured":"Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation. 2010;121(7):906\u201315.","journal-title":"Circulation"},{"issue":"12","key":"1390_CR11","doi-asserted-by":"publisher","first-page":"7506","DOI":"10.4049\/jimmunol.174.12.7506","volume":"174","author":"IE Dumitriu","year":"2005","unstructured":"Dumitriu IE, Baruah P, Valentinis B, Voll RE, Herrmann M, Nawroth PP, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol. 2005;174(12):7506\u201315.","journal-title":"J Immunol"},{"issue":"4","key":"1390_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","volume":"32","author":"KK Eklund","year":"2012","unstructured":"Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A. Crit Rev Immunol. 2012;32(4):335\u201348.","journal-title":"Crit Rev Immunol"},{"key":"1390_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004600","author":"I Ferrigno","year":"2024","unstructured":"Ferrigno I, Bonacini M, Rossi A, Nicastro M, Muratore F, Boiardi L, et al. Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies. RMD Open. 2024. https:\/\/doi.org\/10.1136\/rmdopen-2024-004600.","journal-title":"RMD Open"},{"issue":"4","key":"1390_CR14","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.4049\/jimmunol.1402481","volume":"194","author":"M Frank","year":"2015","unstructured":"Frank M, Hennenberg EM, Eyking A, Runzi M, Gerken G, Scott P, et al. Tlr signaling modulates side effects of anticancer therapy in the small intestine. J Immunol. 2015;194(4):1983\u201395.","journal-title":"J Immunol"},{"issue":"9","key":"1390_CR15","first-page":"2240","volume":"13","author":"B Fu","year":"2020","unstructured":"Fu B, Lu X, Zhao EY, Wang JX, Peng SM. HMGB1-induced autophagy promotes extracellular matrix degradation leading to intervertebral disc degeneration. Int J Clin Exp Pathol. 2020;13(9):2240\u20138.","journal-title":"Int J Clin Exp Pathol"},{"issue":"5","key":"1390_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.semarthrit.2003.09.007","volume":"33","author":"MA Gonzalez-Gay","year":"2004","unstructured":"Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33(5):289\u201393.","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"1390_CR17","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3899\/jrheum.160466","volume":"43","author":"MA Gonzalez-Gay","year":"2016","unstructured":"Gonzalez-Gay MA, Castaneda S, Llorca J. Giant cell arteritis: visual loss is our major concern. J Rheumatol. 2016;43(8):1458\u201361.","journal-title":"J Rheumatol"},{"issue":"10103","key":"1390_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/S0140-6736(17)31825-1","volume":"390","author":"MA Gonzalez-Gay","year":"2017","unstructured":"Gonzalez-Gay MA, Matteson EL, Castaneda S. Polymyalgia rheumatica. Lancet. 2017;390(10103):1700\u201312.","journal-title":"Lancet"},{"issue":"4","key":"1390_CR19","doi-asserted-by":"publisher","first-page":"101424","DOI":"10.1016\/j.berh.2019.06.006","volume":"33","author":"MA Gonzalez-Gay","year":"2019","unstructured":"Gonzalez-Gay MA, Prieto-Pena D, Martinez-Rodriguez I, Calderon-Goercke M, Banzo I, Blanco R, et al. Early large vessel systemic vasculitis in adults. Best Pract Res Clin Rheumatol. 2019;33(4):101424.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"1390_CR20","first-page":"774","volume":"41","author":"MA Gonzalez-Gay","year":"2023","unstructured":"Gonzalez-Gay MA, Vicente-Rabaneda EF, Heras-Recuero E, Castaneda S. Polymyalgia rheumatica: when should we suspect an underlying large vessel vasculitis? Clin Exp Rheumatol. 2023;41(4):774\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"1390_CR21","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1136\/ard.43.5.721","volume":"43","author":"RG Grau","year":"1984","unstructured":"Grau RG, Kassan SS, Franks JJ, Kaplan H, Walker SH, Tan EM. Fibrin(ogen)olysis in polymyalgia rheumatica and temporal arteritis: preliminary findings on association with disease activity. Ann Rheum Dis. 1984;43(5):721\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1390_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0002-9394(99)80192-5","volume":"125","author":"SS Hayreh","year":"1998","unstructured":"Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125(4):509\u201320.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"1390_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm1191","volume":"11","author":"V Hornung","year":"2005","unstructured":"Hornung V, Guenthner-Biller M, Bourquin C, Ablasser A, Schlee M, Uematsu S, et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nat Med. 2005;11(3):263\u201370.","journal-title":"Nat Med"},{"issue":"8","key":"1390_CR24","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American college of rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33(8):1122\u20138.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1390_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1084\/jem.20030850","volume":"199","author":"W Ma-Krupa","year":"2004","unstructured":"Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2004;199(2):173\u201383.","journal-title":"J Exp Med"},{"issue":"6","key":"1390_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/ni.1733","volume":"10","author":"G Mancuso","year":"2009","unstructured":"Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, et al. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol. 2009;10(6):587\u201394.","journal-title":"Nat Immunol"},{"issue":"3","key":"1390_CR27","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/rheumatology\/kes294","volume":"52","author":"EM McCarthy","year":"2013","unstructured":"McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, et al. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica. Rheumatology (Oxford). 2013;52(3):465\u201371.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"1390_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3899\/jrheum.131055","volume":"41","author":"EM McCarthy","year":"2014","unstructured":"McCarthy EM, MacMullan PA, Al-Mudhaffer S, Madigan A, Donnelly S, McCarthy CJ, et al. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study. J Rheumatol. 2014;41(5):931\u20137.","journal-title":"J Rheumatol"},{"key":"1390_CR29","doi-asserted-by":"publisher","first-page":"107377","DOI":"10.1016\/j.clineuro.2022.107377","volume":"221","author":"HM Muniz Castro","year":"2022","unstructured":"Muniz Castro HM, Bhattacharjee MB, Chaudhry IA, Chuang AZ, Mankiewicz KA, Adesina OO. Diagnosis of giant cell arteritis using clinical, laboratory, and histopathological findings in patients undergoing temporal artery biopsy. Clin Neurol Neurosurg. 2022;221:107377.","journal-title":"Clin Neurol Neurosurg"},{"issue":"11","key":"1390_CR30","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1093\/rheumatology\/kew001","volume":"55","author":"L O'Neill","year":"2016","unstructured":"O\u2019Neill L, Molloy ES. The role of toll like receptors in giant cell arteritis. Rheumatology (Oxford). 2016;55(11):1921\u201331.","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"1390_CR31","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1002\/art.39217","volume":"67","author":"L O'Neill","year":"2015","unstructured":"O\u2019Neill L, Rooney P, Molloy D, Connolly M, McCormick J, McCarthy G, et al. Regulation of inflammation and angiogenesis in giant cell arteritis by acute-phase serum amyloid A. Arthritis Rheumatol. 2015;67(9):2447\u201356.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1390_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1080\/01658107.2019.1604763","volume":"43","author":"RA Ostrowski","year":"2019","unstructured":"Ostrowski RA, Metgud S, Tehrani R, Jay WM. Varicella zoster virus in giant cell arteritis: a review of current medical literature. Neuroophthalmology. 2019;43(3):159\u201370.","journal-title":"Neuroophthalmology"},{"issue":"7","key":"1390_CR33","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3899\/jrheum.081286","volume":"36","author":"R Palomino-Morales","year":"2009","unstructured":"Palomino-Morales R, Torres O, Vazquez-Rodriguez TR, Morado IC, Castaneda S, Callejas-Rubio JL, et al. Association between toll-like receptor 4 gene polymorphism and biopsy-proven giant cell arteritis. J Rheumatol. 2009;36(7):1501\u20136.","journal-title":"J Rheumatol"},{"issue":"5","key":"1390_CR34","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1136\/ard.40.5.493","volume":"40","author":"JR Park","year":"1981","unstructured":"Park JR, Jones JG, Hazleman BL. Relationship of the erythrocyte sedimentation rate to acute phase proteins in polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis. 1981;40(5):493\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1390_CR35","doi-asserted-by":"publisher","first-page":"7370","DOI":"10.1074\/jbc.M306793200","volume":"279","author":"JS Park","year":"2004","unstructured":"Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, et al. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370\u20137.","journal-title":"J Biol Chem"},{"issue":"7","key":"1390_CR36","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1080\/08916930903002495","volume":"42","author":"K Piggott","year":"2009","unstructured":"Piggott K, Biousse V, Newman NJ, Goronzy JJ, Weyand CM. Vascular damage in giant cell arteritis. Autoimmunity. 2009;42(7):596\u2013604.","journal-title":"Autoimmunity"},{"issue":"12","key":"1390_CR37","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1136\/ard-2022-223480","volume":"81","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology\/EULAR classification criteria for giant cell arteritis. Ann Rheum Dis. 2022a;81(12):1647\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"1390_CR38","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1002\/art.42325","volume":"74","author":"C Ponte","year":"2022","unstructured":"Ponte C, Grayson PC, Robson JC, Suppiah R, Gribbons KB, Judge A, et al. 2022 American College of Rheumatology\/EULAR Classification Criteria for Giant Cell Arteritis. Arthritis Rheumatol. 2022b;74(12):1881\u20139.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1390_CR39","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.108.789172","volume":"118","author":"O Pryshchep","year":"2008","unstructured":"Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation. 2008;118(12):1276\u201384.","journal-title":"Circulation"},{"issue":"9","key":"1390_CR40","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/art.1780360913","volume":"36","author":"NE Roche","year":"1993","unstructured":"Roche NE, Fulbright JW, Wagner AD, Hunder GG, Goronzy JJ, Weyand CM. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum. 1993;36(9):1286\u201394.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 10","key":"1390_CR41","first-page":"1972","volume":"60","author":"L Sailler","year":"2009","unstructured":"Sailler L, Lapeyre-Mestre M, Geffray L, Letellier P, Liozon E, De La Roque P, et al. Adding hydroxychloroquine to prednisone does not improve the outcome in giant cell arteritis: a double blind randomized controlled trial. Arthritis Rheum. 2009;60(Suppl 10):1972.","journal-title":"Arthritis Rheum"},{"issue":"6 Suppl 32","key":"1390_CR42","first-page":"S23","volume":"21","author":"C Salvarani","year":"2003","unstructured":"Salvarani C, Cantini F, Boiardi L, Hunder GG. Laboratory investigations useful in giant cell arteritis and Takayasu\u2019s arteritis. Clin Exp Rheumatol. 2003;21(6 Suppl 32):S23\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"1390_CR43","doi-asserted-by":"publisher","unstructured":"Samson M, Dasgupta B, Sammel AM, Salvarani C, Pagnoux C, Hajj-Ali R, et al. Targeting interleukin-6 pathways in giant cell arteritis management: A narrative review of evidence. Autoimmun Rev. 2024:103716. https:\/\/doi.org\/10.1016\/j.autrev.2024.103716","DOI":"10.1016\/j.autrev.2024.103716"},{"issue":"9","key":"1390_CR44","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3899\/jrheum.120987","volume":"40","author":"H Schierbeck","year":"2013","unstructured":"Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius A, et al. HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration. J Rheumatol. 2013;40(9):1604\u201313.","journal-title":"J Rheumatol"},{"issue":"1","key":"1390_CR45","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1038\/s41598-019-39846-3","volume":"9","author":"M Schuchardt","year":"2019","unstructured":"Schuchardt M, Prufer N, Tu Y, Herrmann J, Hu XP, Chebli S, et al. Dysfunctional high-density lipoprotein activates toll-like receptors via serum amyloid a in vascular smooth muscle cells. Sci Rep. 2019;9(1):3421.","journal-title":"Sci Rep"},{"issue":"5","key":"1390_CR46","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejim.2007.01.005","volume":"18","author":"G Slobodin","year":"2007","unstructured":"Slobodin G, Lurie M, Bejar J, Rozenbaum M, Boulman N, Rosner I. Biopsy-negative giant cell arteritis: does anti-CD83 immunohistochemistry advance the diagnosis? Eur J Intern Med. 2007;18(5):405\u20138.","journal-title":"Eur J Intern Med"},{"issue":"5","key":"1390_CR47","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","volume":"167","author":"ST Smiley","year":"2001","unstructured":"Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001;167(5):2887\u201394.","journal-title":"J Immunol"},{"issue":"5","key":"1390_CR48","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/jcm8050582","volume":"8","author":"T Smutny","year":"2019","unstructured":"Smutny T, Barvik I, Veleta T, Pavek P, Soukup T. Genetic predispositions of glucocorticoid resistance and therapeutic outcomes in polymyalgia rheumatica and giant cell arteritis. J Clin Med. 2019;8(5):582.","journal-title":"J Clin Med"},{"issue":"5","key":"1390_CR49","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ni1457","volume":"8","author":"J Tian","year":"2007","unstructured":"Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487\u201396.","journal-title":"Nat Immunol"},{"issue":"7","key":"1390_CR50","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","volume":"19","author":"A Tomelleri","year":"2023","unstructured":"Tomelleri A, van der Geest KSM, Khurshid MA, Sebastian A, Coath F, Robbins D, et al. Disease stratification in GCA and PMR: state of the art and future perspectives. Nat Rev Rheumatol. 2023;19(7):446\u201359.","journal-title":"Nat Rev Rheumatol"},{"issue":"27","key":"1390_CR51","doi-asserted-by":"publisher","first-page":"6502","DOI":"10.1021\/bi9004304","volume":"48","author":"I Ugrinova","year":"2009","unstructured":"Ugrinova I, Pashev IG, Pasheva EA. Nucleosome binding properties and co-remodeling activities of native and in vivo acetylated HMGB-1 and HMGB-2 proteins. Biochemistry. 2009;48(27):6502\u20137.","journal-title":"Biochemistry"},{"issue":"15","key":"1390_CR52","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1161\/01.CIR.0000032146.75113.EE","volume":"106","author":"A Vink","year":"2002","unstructured":"Vink A, Schoneveld AH, van der Meer JJ, van Middelaar BJ, Sluijter JP, Smeets MB, et al. In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation. 2002;106(15):1985\u201390.","journal-title":"Circulation"},{"issue":"11","key":"1390_CR53","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.autrev.2015.07.010","volume":"14","author":"C Wang","year":"2015","unstructured":"Wang C, de Souza AW, Westra J, Bijl M, Chen M, Zhao MH, et al. Emerging role of high mobility group box 1 in ANCA-associated vasculitis. Autoimmun Rev. 2015;14(11):1057\u201365.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"1390_CR54","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/CIRCRESAHA.122.322128","volume":"132","author":"CM Weyand","year":"2023","unstructured":"Weyand CM, Goronzy JJ. Immunology of giant cell arteritis. Circ Res. 2023;132(2):238\u201350.","journal-title":"Circ Res"},{"key":"1390_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1196\/annals.1358.023","volume":"1062","author":"CM Weyand","year":"2005","unstructured":"Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci. 2005;1062:195\u2013208.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1390_CR56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1021\/cb3005897","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu J, Powell F, Larsen NA, Lai Z, Byth KF, Read J, et al. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol. ACS Chem Biol. 2013;8(3):643\u201350.","journal-title":"ACS Chem Biol"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-025-01390-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-025-01390-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:01:48Z","timestamp":1766048508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-025-01390-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1390"],"URL":"https:\/\/doi.org\/10.1186\/s10020-025-01390-4","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the recommendations of the institutional ethic commission of the University Hospital La Princesa, Madrid, Spain (internal code number 5102\/2023) and the Medical University of Innsbruck (AN3950 287\/4.5 431\/AM2 (4555a)). All subjects gave a written informed consent prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors S. Seidlberger, G. Wietzorrek G, JA. Jim\u00e9nez-Heffernan, M. Pardines, M. de las Fuentes Monreal and S. Santos-Sierra declare they have no financial interests. Author M. Schirmer received educational grants from AbbVie Austria. M. A. Gonzalez-Gay has had consultation fees\/participation in company sponsored speaker\u00b4s bureau from GSK, Otsuka, Sanofi, Amgen and Novo-Nordisk. S. Casta\u00f1eda received consultation fees and participated in the company sponsored speaker\u2019s bureau from Amgen, Gr\u00fcnenthal Pharma, Eli-Lilly, Gedeon-Richter, Janssen, Roche, and UCB Spain. None of the financial disclosures has any relation to this work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"331"}}